Conjugates for the treatment of mesothelioma

Details for Australian Patent Application No. 2009248105 (hide)

Owner MolMed S.p.A.

Inventors Bordignon, Claudio; Lambiase, Antonio

Agent Davies Collison Cave

Pub. Number AU-A-2009248105

PCT Pub. Number WO2009/138396

Priority 08008872.7 13.05.08 EP

Filing date 12 May 2009

Wipo publication date 19 November 2009

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

2 December 2010 PCT application entered the National Phase

  PCT publication WO2009/138396 Priority application(s): WO2009/138396

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009248118-Method of reducing torsional oscillations in the power train of a wind turbine

2009248102-5-[5-[2-(3,5bis(trifluoromethyl)phenyl)-2-methylpropanoylmethylamino]-4-(4-fluoro-2methylphenyl)]-2-pyridinyl-2-alkyl-prolinamide as NK1 receptor antagonists